Join intoDNA workshop at the PARP Family & ADP-ribosylation meeting
March 31st
Cold Spring Harbor Lab
STRIDE. Sensitive Technology for DNA break detection.
Interested to find out why you should consider adding STRIDE to your assay toolbox?
Join us at the PARP Family and ADP-ribosylation meeting on March 31st, following the morning session where the inventor of the technology Magda Kordon, PhD will discuss how STRIDE is enabling scientists to label single- and double-strand DNA breaks at a new precision level giving them a better insight into mechanisms of action and pharmacodynamics of DDR inhibitors as well as other genotoxic agents.
Magda Kordon, CEO
intoDNA workshop will include:
- Overview of insights into drugs’ mechanisms of action, efficiency, pharmacodynamics and safety with STRIDE
- Comparison between STRIDE technology for DNA break detection and other tools, including antibody- and IF-based assays
- How to design a robust, informative study applying STRIDE technology combined with other assays, including analysis of various DNA repair markers
- Application of STRIDE in different types of biological material, including FFPE liquid biopsies or solid tissues
- Overview of insights into drugs’ mechanisms of action, efficiency, pharmacodynamics and safety with STRIDE
- Comparison between STRIDE technology for DNA break detection and other tools, including antibody- and IF-based assays
- How to design a robust, informative study applying STRIDE technology combined with other assays, including analysis of various DNA repair markers
- Application of STRIDE in different types of biological material, including FFPE liquid biopsies or solid tissues
About Magda Kordon
Dr Magda Kordon earned her PhD in Cell Biophysics from Jagiellonian University and was a visiting PhD student at Prof. Lloyd Trotman's Lab at Cold Spring Harbor Laboratory.
60+projects completed |
20+satisfied clients |
In 2017, she founded intoDNA, a company built on innovative patent-protected STRIDE technology with a mission to enable DNA break detection at higher precision. She has authored the publication and the patent on DNA damage analysis with STRIDE.
With more than a decade of research experience in biophysics and cell biology, she leads intoDNA and the STRIDE technology into new business verticals to support consistently growing numbers of customers in diagnosing DNA damage in a growing number of areas.
60+projects completed |
20+satisfied clients |